Cytokinetics Inc. buy B. Riley
Start price
21.01.26
/
50%
€55.00
Target price
21.01.27
-
Performance (%)
-2.73%
Price
04.03.26
€53.50
Summary
This prediction is currently active. With a performance of -2.73%, the BUY prediction for Cytokinetics Inc. by B__Riley is down slightly. This prediction currently runs until 21.01.27. The prediction end date can be changed by B__Riley at any time. B__Riley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | 0.000% | 0.000% |
| iShares Core DAX® | -6.016% | -4.595% |
| iShares Nasdaq 100 | 0.511% | 0.164% |
| iShares Nikkei 225® | -7.156% | -2.215% |
| iShares S&P 500 | -0.257% | -0.841% |
Comments by B__Riley for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (NASDAQ:CYTK) had its "buy" rating reaffirmed by analysts at B. Riley.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by B__Riley for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€41.00
22.09.25
22.09.25
€68.18
22.09.26
22.09.26
30.49%
04.03.26
04.03.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€44.60
04.06.24
04.06.24
€84.53
04.06.25
04.06.25
-35.43%
05.06.25
05.06.25
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€33.40
07.11.23
07.11.23
€61.81
07.11.24
07.11.24
61.68%
08.11.24
08.11.24

